Navigation Links
Prolia™ (denosumab) Receives Best New Drug Honor at Scrip Awards
Date:11/5/2010

d Form 8-K.  

Please refer to Amgen's most recent Forms 10-K, 10-Q and 8-K for additional information on the uncertainties and risk factors related to our business. Unless otherwise noted, Amgen is providing this information as of the date of this news release and expressly disclaims any duty to update information contained in this news release.

No forward-looking statement can be guaranteed and actual results may differ materially from those we project. Discovery or identification of new product candidates or development of new indications for existing products cannot be guaranteed and movement from concept to product is uncertain; consequently, there can be no guarantee that any particular product candidate or development of a new indication for an existing product will be successful and become a commercial product. Further, preclinical results do not guarantee safe and effective performance of product candidates in humans. The complexity of the human body cannot be perfectly, or sometimes, even adequately modeled by computer or cell culture systems or animal models. The length of time that it takes for us to complete clinical trials and obtain regulatory approval for product marketing has in the past varied and we expect similar variability in the future. We develop product candidates internally and through licensing collaborations, partnerships and joint ventures. Product candidates that are derived from relationships may be subject to disputes between the parties or may prove to be not as effective or as safe as we may have believed at the time of entering into such relationship. Also, we or others could identify safety, side effects or manufacturing problems with our products after they are on the market. Our business may be impacted by government investigations, litigation and products liability claims. We depend on third parties for a significant portion of our manufacturing capacity for the supply of certain of our current and future prod
'/>"/>

SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
3. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
4. Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
5. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
6. CryoCor Receives FDA Approval for Right Atrial Flutter
7. Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
8. Dimericine(R) Receives FDA Fast Track Designation for Treatment Of Photosensitivity in XP Patients
9. Poniard Pharmaceuticals Receives FDA Fast Track Designation for Picoplatin for Treatment of Small Cell Lung Cancer
10. Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma
11. The Female Health Company Receives USAID DELIVER PROJECT Order for 5 Million Units
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... -- LCA-Vision Inc. (NASDAQ: LCAV ), a leading provider ... brand, announces that all nominees to the company,s Board of ... of stockholders.  These Directors are: , William ... Gaynor Investment Counsel , John C. Hassan ... Edgar F. Heizer III , Chairman of Manus Health ...
(Date:5/21/2013)... 2013 /PRNewswire-iReach/ -- The 2013 Pharma ChemOutsourcing Show slated ... greatest number of "Emerging" small molecule biotech company ... Alexay .  "No one saw this coming", ... show,s still 4 months away and we may end ... big surprise and great news for attendees". Thecurrent list ...
(Date:5/21/2013)... PARK, N.J. , May 21, 2013 /PRNewswire/ ... the launch of the new Armada corporate website ... to clearly communicate Armada,s unique and first-to-market services ... service company focused on the specialty pharmacy industry. ... continued expansion of the Armada business model in ...
Breaking Medicine Technology:LCA-Vision Reports on Annual Meeting of Stockholders 2LCA-Vision Reports on Annual Meeting of Stockholders 3LCA-Vision Reports on Annual Meeting of Stockholders 4Emerging Pharma at ChemOutsourcing 2013 in Record Numbers for Upcoming September Show 2Armada Announces New Corporate Website to Showcase Expanded Services to Specialty Pharmacy Marketplace 2
... enjoyed widespread use of its flocked swabs line, branded ... of bacterial and viral samples. FLOQSwabs ... to collect more sample and elute the entire sample ... agents. In spite of this success, the company has ...
... Dec. 16, 2010 Astrum Hearing Inc., an organization of ... way affiliated with Astrum Marketing Inc., also known as Astrum ... bankruptcy pending in the Middle District of Florida. In addition, ... "Sears Hearing By Astrum" centers. Astrum Hearing Inc. ...
Cached Medicine Technology:COPAN Files New Patents Following the Development of High Nucleic Acid Yield Flocked Swabs 2Astrum Hearing Inc. Is Not Affiliated with Astrum Hearing Aid Centers or Astrum Marketing 2
(Date:5/21/2013)... (PRWEB) May 21, 2013 Today, Zane ... HSA and FSA accounts. Zane Benefits, which provides ... benefits, is the leader in defined contribution ... arrangements . , According to Zane Benefits’ website, the ... was signed into law in 2010 and impacts many ...
(Date:5/21/2013)... May 21, 2013 Two executives from ... (SBG) will identify which strategies can be most effective ... care to the members who are taking them, in ... Inc., “How to Manage Specialty Drugs to Reduce ... are now the main driver for rising prescription drug ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 While North ... synonymous with comprehensive travel guides. Brunswick Plantation & Golf ... packages that include access to 27 holes of "Top10" ... courses in North Carolina, knowing the Top 10 ... Lodges takes away the overwhelming task of selecting the ...
(Date:5/21/2013)... 21, 2013 Octo Consulting Group, ... management consulting solutions to the Federal marketplace, has ... In the newly created role, Denny will ... of the firm’s business development function to include ... functions, and leading strategies to achieve the firm’s ...
(Date:5/21/2013)... HealthDay Reporter , , TUESDAY, May 21 (HealthDay News) -- ... for patients having severe bouts of chronic obstructive pulmonary ... of glucocorticoid treatment with prednisone to treat COPD flare-ups ... with fewer chances for adverse side effects, they said. ... of treatment was not less effective than 14 days," ...
Breaking Medicine News(10 mins):Health News:Zane Benefits Publishes New Information on HRA, HSA and FSA Accounts 2Health News:Zane Benefits Publishes New Information on HRA, HSA and FSA Accounts 3Health News:Consulting Firm Execs to Discuss Strategies for Effective Management of Specialty Drugs in AIS’s May 30 Webinar 2Health News:Brunswick Plantation & Golf Resort Named in Top 10 Golf Resorts in North Carolina 2Health News:Octo Consulting Group Appoints Tracy Denny as Vice President of Business Development 2Health News:COPD Patients May Do Fine With Shorter Course of Steroids 2Health News:COPD Patients May Do Fine With Shorter Course of Steroids 3
... following is a statement from Matthew L. Myers, ... Mayor Sheila Dixon and Baltimore City Health Commissioner ... city,s children and health by issuing final regulations ... cigars. Under the regulation, cheap cigars would have ...
... Support for SCHIP ReauthorizationWASHINGTON, Jan. 14 The following ... the Speaker of the House: Divided We Fail Partnership ... SEIU) , "On behalf of Divided We Fail, ... strengthen the State Children,s Health Insurance Program (SCHIP). Our ...
... highlights:-- Cholesterol-lowering drug adherence drops with an increase ... for 90 straight days without medication was three ... group and twice as high in patients in ... exempt group (received prescriptions without a co-payment).-- Researchers ...
... Delivery SystemCARLSBAD, Calif., Jan. 14 SkinMedica, Inc. ... Wash, the only prescription benzoyl peroxide wash ... system, for the treatment of mild to moderate ... 7% benzoyl peroxide.(Photo: http://www.newscom.com/cgi-bin/prnh/20090114/LA58962 )NeoBenz ...
... Experience with Complex Rehab MarketHOUSTON, Jan. 14 Anne ... of experience, has joined Alliance Seating & Mobility ... complex rehab companies. Kieschnik is an Assistive Technology ... in Houston, Texas, for ASM ( www.alliance-seating.com ) and ...
... Association rapid access journal reportStudy highlights:, , ... determine the odds of having cardiovascular disease within 10 years may ... Most adults 50 years and younger have a low ... for heart disease. , Researchers ...
Cached Medicine News:Health News:Baltimore's Ban on Sale of Single, Cheap Cigars Will Protect Kids and Health 2Health News:Health Care For 11 Million Children 2Health News:Health Care For 11 Million Children 3Health News:Health Care For 11 Million Children 4Health News:Co-Payment Increases Result in Gaps in Veterans' Prescription Usage 2Health News:Co-Payment Increases Result in Gaps in Veterans' Prescription Usage 3Health News:Co-Payment Increases Result in Gaps in Veterans' Prescription Usage 4Health News:SkinMedica(R) Launches NeoBenz(R) Micro Wash for Acne 2Health News:SkinMedica(R) Launches NeoBenz(R) Micro Wash for Acne 3Health News:Veteran Rehab Specialist, Anne Kieschnik, Joins Fast-Growing Alliance Seating & Mobility In Texas 2Health News:Veteran Rehab Specialist, Anne Kieschnik, Joins Fast-Growing Alliance Seating & Mobility In Texas 3Health News:Half of Adults 50 and Younger With Low 10-Year Risk of CVD Have High Lifetime Risk 2Health News:Half of Adults 50 and Younger With Low 10-Year Risk of CVD Have High Lifetime Risk 3
For the quantitative in vitro determination of Valproic Acid in human serum...
For the quantitative in vitro determination of Microalbumin in human urine....
Determination of the Thrombin Time by STA Analyzers. Freeze-dried human thrombin (1.5NIH units/mL) with calcium....
Determination of Prothrombin Time (PT) by STA Analyzers (ISI~1.3).Freeze-dried rabbit brain thromboplastin with heparin inhibitor....
Medicine Products: